Post-Transplant, eGFR Impacts Cardio Risk Independently

This article originally appeared here.
Post-Transplant, eGFR Impacts Cardio Risk Independently
Post-Transplant, eGFR Impacts Cardio Risk Independently

In stable kidney transplant recipients, kidney function, as determined by estimated glomerular filtration rate (eGFR), is independently associated with cardiovascular (CVD) events and death, according to research published online in the American Journal of Transplantation.

Daniel E. Weiner, MD, of Tufts Medical Center in Boston, and colleagues conducted a post hoc analysis of data from 4,016 participants in the Folic Acid for Vascular Outcome Reduction in Transplantation trial to assess CVD and mortality risk factors in renal transplant recipients. The researchers found that 20% of participants had prior CVD, and the mean eGFR was 49 mL/min/1.73 m². Over a median of 3.8 years, the researchers identified a total of 527 CVD events in 3,676 participants for whom complete data were available. For those with eGFR values below 45 mL/min/1.73 m², for every 5 mL/min/1.73 m² increase in eGFR, the risk of CVD and death was 15%lower in adjusted analyses. No association was found for those with an eGFR above 45 mL/min/1.73 m².

"In conclusion, in stable kidney transplant recipients, lower eGFR is independently associated with adverse events, suggesting that reduced kidney function itself rather than preexisting comorbidity may lead to CVD," the authors wrote.

PamLab provided the high- and low-dose multivitamins used in the study.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters